BioLargo, Inc. Share Price Other OTC
Equities
BLGO
US09065A1007
Commodity Chemicals
Sales 2024 * | 19.05M 1.59B | Sales 2025 * | 25.76M 2.15B | Capitalization | 104M 8.7B |
---|---|---|---|---|---|
Net income 2024 * | -1M -83.38M | Net income 2025 * | - 0 | EV / Sales 2024 * | 5.48 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.05 x |
P/E ratio 2024 * |
-35.3
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.75% |
Latest transcript on BioLargo, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 01/02/01 |
Director of Finance/CFO | 68 | 01/08/01 | |
Chief Operating Officer | 55 | 01/02/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 28/06/28 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 01/07/01 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 01/02/01 |
1st Jan change | Capi. | |
---|---|---|
+5.14% | 103B | |
-5.63% | 63.04B | |
+39.52% | 39.06B | |
+12.91% | 37.58B | |
+7.41% | 33.24B | |
+6.85% | 19.22B | |
+12.86% | 16.83B | |
+7.73% | 15.03B | |
+16.93% | 14.96B |